Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06312592
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-02-29
Brief Title:
GBV Prevention Mitigation and Response in Colombia
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Owning Rights and Protection GBV Prevention Mitigation and Response in Colombia
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
As of August 2021 Colombia hosts the vast majority of Venezuelan refugees and migrants UNHCR 2022 For vulnerable refugees and migrants in Colombia and especially for women gender-based violence GBV is present during transit and continues in their new homes where xenophobia lack of accessible and adequate services lack of safe economic opportunities and lack of information on access to services further increase risk Lack of livelihood opportunities also affect vulnerable refugees and migrants especially women with barriers to employment including lack of information precarious working conditions with lower payments and longer working days with increasing risks of labor exploitation xenophobia and discrimination limited access to formal labor markets lack of access to financial services among others To address these issues the investigators are conducting a pilot randomized-controlled trial RCT of HIAS Entrepreneurship School with Gender Lens ESGL a methodology that targets GBV survivors and women at-risk to help them develop business ideas access needed support for the prevention of and response to GBV exploitation and trafficking and improve participants overall self-reliance The pilot RCT will be conducted within three cities in Colombia approximately 80 eligible participants will be enrolled in each city and randomized to a treatment or control arm Survey questionnaires will be administered to participants at baseline eight months following baseline endline and 3-4 months after endline Outcomes of interest include household self-reliance mental health empowerment decision-making and GBV risk and knowledge
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None